To examine the role of the variants of the PTPN22 and HLA–DRB1 genes as predictors of mortality in inflammatory polyarthritis (IP) and rheumatoid arthritis (RA). This evidence concerns the gene HLA-DRB1 and rheumatoid arthritis.